CN Stock MarketDetailed Quotes

003020 Hefei Lifeon Pharmaceutical

Watchlist
  • 24.69
  • +0.57+2.36%
Trading May 23 14:31 CST
3.94BMarket Cap20.64P/E (TTM)

Hefei Lifeon Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-58.90%333.62M
-26.31%1.9B
-19.52%1.52B
3.14%1.27B
29.14%811.82M
13.46%2.58B
13.77%1.89B
14.47%1.23B
14.48%628.62M
20.01%2.27B
Operating revenue
-58.90%333.62M
-26.31%1.9B
-19.52%1.52B
3.14%1.27B
29.14%811.82M
13.46%2.58B
13.77%1.89B
14.47%1.23B
14.48%628.62M
20.01%2.27B
Other operating revenue
----
60.75%14.25M
----
75.17%6.11M
----
-24.67%8.86M
----
-38.67%3.49M
----
-7.60%11.77M
Total operating cost
-57.86%307.76M
-29.21%1.68B
-21.69%1.36B
1.23%1.13B
27.21%730.37M
13.36%2.38B
13.27%1.73B
13.92%1.12B
14.60%574.13M
20.09%2.1B
Operating cost
-79.93%103.4M
-42.90%922.2M
-29.85%815.4M
-3.32%721.72M
34.70%515.2M
18.23%1.62B
16.90%1.16B
16.79%746.53M
14.77%382.49M
8.36%1.37B
Operating tax surcharges
-15.14%4.8M
14.90%18.34M
6.89%12.8M
25.29%9.98M
32.29%5.66M
-1.88%15.96M
5.00%11.98M
13.33%7.97M
20.61%4.28M
31.29%16.26M
Operating expense
-13.61%158.41M
-2.91%598.45M
-8.77%426.7M
7.20%331.81M
12.82%183.37M
1.84%616.39M
3.69%467.73M
7.07%309.51M
13.57%162.52M
53.69%605.24M
Administration expense
19.01%18.05M
4.76%61.96M
17.64%46.56M
20.82%31.07M
29.98%15.16M
31.83%59.14M
22.94%39.58M
24.04%25.72M
22.43%11.67M
14.94%44.86M
Financial expense
71.63%-440.98K
7.13%-3.29M
-916.36%-3.77M
-1,082.64%-2.4M
-5,121.28%-1.55M
-121.63%-3.55M
71.49%-371.19K
124.66%244.06K
96.61%-29.77K
51.36%-1.6M
-Interest expense (Financial expense)
106.40%230.38K
43.93%1.28M
254.87%532.67K
93.44%1.25M
-83.76%111.61K
-34.52%890.23K
-16.30%150.1K
-15.21%643.66K
200.37%687.45K
455.73%1.36M
-Interest Income (Financial expense)
45.08%-855.22K
-5.90%-4.65M
-155.71%-4.39M
-134.75%-3.7M
-84.13%-1.56M
-31.24%-4.39M
32.57%-1.72M
18.72%-1.57M
18.32%-845.65K
22.12%-3.35M
Research and development
87.78%23.55M
15.11%84.96M
14.40%59.93M
37.26%42.8M
-5.00%12.54M
12.06%73.8M
22.13%52.39M
7.18%31.18M
6.41%13.2M
52.06%65.86M
Credit Impairment Loss
49.93%-790.34K
-780.30%-2.11M
-137.21%-3.85M
-339.74%-5.76M
-15.59%-1.58M
-115.20%-239.15K
23.55%-1.62M
22.67%-1.31M
9.65%-1.37M
71.74%-111.13K
Asset Impairment Loss
14.19%-2.07M
-143.32%-9.2M
-57.11%-5.5M
-21.54%-3.16M
-251.81%-2.41M
-34.48%-3.78M
-142.42%-3.5M
-258.75%-2.6M
0.31%-685.74K
-171.29%-2.81M
Other net revenue
189.80%3.16M
-1.14%37.09M
-28.66%24.45M
257.67%14.22M
-922.35%-3.52M
135.81%37.52M
398.37%34.27M
23.15%3.98M
230.04%427.87K
75.79%15.91M
Fair value change income
25,297.63%972.79K
926.44%315.52K
188.05%2.39M
-43.16%1.38M
67.86%-3.86K
-256.00%-38.18K
-33.74%829.19K
86.35%2.43M
---12.01K
---10.72K
Invest income
1,038.88%3.43M
-14.88%27.49M
-10.12%27.5M
2,776.60%19.79M
-223.33%-365.67K
187.41%32.29M
379.18%30.6M
-127.09%-739.48K
-109.23%-113.09K
--11.24M
-Including: Investment income associates
392.73%1.94M
126.44%1.06M
----
----
53.97%-662.67K
-21.23%-4M
----
----
-1,221.38%-1.44M
---3.3M
Asset deal income
----
----
----
99.84%-3.82K
79.37%-1.36K
-8,364.51%-2.54M
-10,261.63%-2.51M
-9,246.92%-2.41M
56.55%-6.59K
1.82%-30.05K
Other revenue
91.41%1.61M
74.10%20.59M
-62.67%3.91M
-77.07%1.97M
-67.70%843.37K
54.85%11.83M
269.92%10.47M
424.29%8.6M
328.92%2.61M
-27.33%7.64M
Operating profit
-62.76%29.02M
6.34%255.27M
-1.74%191.33M
31.22%147.02M
41.89%77.92M
24.73%240.05M
37.96%194.72M
20.62%112.05M
14.90%54.92M
22.24%192.45M
Add:Non operating Income
113.46%237.28K
641.47%3.15M
-29.88%254.04K
-15.45%190.69K
21.73%111.16K
-86.39%424.2K
-88.45%362.29K
-92.59%225.53K
43.45%91.32K
818.43%3.12M
Less:Non operating expense
25,623.96%244.05K
52.30%998.83K
44.83%678K
106.28%561.61K
-99.46%948.74
-10.90%655.81K
-1.99%468.13K
-20.18%272.26K
140.52%177.08K
-12.06%736.03K
Total profit
-62.83%29.01M
7.34%257.42M
-1.90%190.91M
30.94%146.65M
42.32%78.03M
23.09%239.82M
35.34%194.61M
17.16%112M
14.74%54.83M
24.15%194.84M
Less:Income tax cost
-86.94%1.55M
-23.03%23.53M
-24.87%18.08M
12.23%15.52M
54.36%11.89M
35.24%30.57M
30.38%24.06M
15.17%13.83M
26.41%7.7M
3.59%22.61M
Net profit
-58.49%27.46M
11.77%233.88M
1.34%172.83M
33.57%131.13M
40.35%66.14M
21.50%209.25M
36.07%170.55M
17.45%98.17M
13.04%47.13M
27.47%172.23M
Net profit from continuing operation
-58.49%27.46M
11.77%233.88M
1.34%172.83M
33.57%131.13M
40.35%66.14M
21.50%209.25M
36.07%170.55M
17.45%98.17M
13.04%47.13M
27.47%172.23M
Less:Minority Profit
---2.92M
--7.21M
--1.46M
----
----
----
----
----
----
----
Net profit of parent company owners
-54.08%30.37M
8.33%226.67M
0.48%171.38M
33.57%131.13M
40.35%66.14M
21.50%209.25M
36.07%170.55M
17.45%98.17M
13.04%47.13M
27.47%172.23M
Earning per share
Basic earning per share
-53.66%0.19
6.77%1.42
0.00%1.09
32.26%0.82
7.89%0.41
-6.99%1.33
4.73%1.09
-10.14%0.62
-15.56%0.38
-26.29%1.43
Diluted earning per share
-53.66%0.19
6.77%1.42
0.00%1.09
32.26%0.82
7.89%0.41
-6.99%1.33
4.73%1.09
-10.14%0.62
-15.56%0.38
-26.29%1.43
Other composite income
Total composite income
-58.49%27.46M
11.77%233.88M
1.34%172.83M
33.57%131.13M
40.35%66.14M
21.50%209.25M
36.07%170.55M
17.45%98.17M
13.04%47.13M
27.47%172.23M
Total composite income of parent company owners
-54.08%30.37M
8.33%226.67M
0.48%171.38M
33.57%131.13M
40.35%66.14M
21.50%209.25M
36.07%170.55M
17.45%98.17M
13.04%47.13M
27.47%172.23M
Total composite income of minority owners
---2.92M
--7.21M
--1.46M
----
----
----
----
----
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Zhonghui Certified Public Accountants (Special General Partnership)
--
--
--
Zhonghui Certified Public Accountants (Special General Partnership)
--
--
--
Zhonghui Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -58.90%333.62M-26.31%1.9B-19.52%1.52B3.14%1.27B29.14%811.82M13.46%2.58B13.77%1.89B14.47%1.23B14.48%628.62M20.01%2.27B
Operating revenue -58.90%333.62M-26.31%1.9B-19.52%1.52B3.14%1.27B29.14%811.82M13.46%2.58B13.77%1.89B14.47%1.23B14.48%628.62M20.01%2.27B
Other operating revenue ----60.75%14.25M----75.17%6.11M-----24.67%8.86M-----38.67%3.49M-----7.60%11.77M
Total operating cost -57.86%307.76M-29.21%1.68B-21.69%1.36B1.23%1.13B27.21%730.37M13.36%2.38B13.27%1.73B13.92%1.12B14.60%574.13M20.09%2.1B
Operating cost -79.93%103.4M-42.90%922.2M-29.85%815.4M-3.32%721.72M34.70%515.2M18.23%1.62B16.90%1.16B16.79%746.53M14.77%382.49M8.36%1.37B
Operating tax surcharges -15.14%4.8M14.90%18.34M6.89%12.8M25.29%9.98M32.29%5.66M-1.88%15.96M5.00%11.98M13.33%7.97M20.61%4.28M31.29%16.26M
Operating expense -13.61%158.41M-2.91%598.45M-8.77%426.7M7.20%331.81M12.82%183.37M1.84%616.39M3.69%467.73M7.07%309.51M13.57%162.52M53.69%605.24M
Administration expense 19.01%18.05M4.76%61.96M17.64%46.56M20.82%31.07M29.98%15.16M31.83%59.14M22.94%39.58M24.04%25.72M22.43%11.67M14.94%44.86M
Financial expense 71.63%-440.98K7.13%-3.29M-916.36%-3.77M-1,082.64%-2.4M-5,121.28%-1.55M-121.63%-3.55M71.49%-371.19K124.66%244.06K96.61%-29.77K51.36%-1.6M
-Interest expense (Financial expense) 106.40%230.38K43.93%1.28M254.87%532.67K93.44%1.25M-83.76%111.61K-34.52%890.23K-16.30%150.1K-15.21%643.66K200.37%687.45K455.73%1.36M
-Interest Income (Financial expense) 45.08%-855.22K-5.90%-4.65M-155.71%-4.39M-134.75%-3.7M-84.13%-1.56M-31.24%-4.39M32.57%-1.72M18.72%-1.57M18.32%-845.65K22.12%-3.35M
Research and development 87.78%23.55M15.11%84.96M14.40%59.93M37.26%42.8M-5.00%12.54M12.06%73.8M22.13%52.39M7.18%31.18M6.41%13.2M52.06%65.86M
Credit Impairment Loss 49.93%-790.34K-780.30%-2.11M-137.21%-3.85M-339.74%-5.76M-15.59%-1.58M-115.20%-239.15K23.55%-1.62M22.67%-1.31M9.65%-1.37M71.74%-111.13K
Asset Impairment Loss 14.19%-2.07M-143.32%-9.2M-57.11%-5.5M-21.54%-3.16M-251.81%-2.41M-34.48%-3.78M-142.42%-3.5M-258.75%-2.6M0.31%-685.74K-171.29%-2.81M
Other net revenue 189.80%3.16M-1.14%37.09M-28.66%24.45M257.67%14.22M-922.35%-3.52M135.81%37.52M398.37%34.27M23.15%3.98M230.04%427.87K75.79%15.91M
Fair value change income 25,297.63%972.79K926.44%315.52K188.05%2.39M-43.16%1.38M67.86%-3.86K-256.00%-38.18K-33.74%829.19K86.35%2.43M---12.01K---10.72K
Invest income 1,038.88%3.43M-14.88%27.49M-10.12%27.5M2,776.60%19.79M-223.33%-365.67K187.41%32.29M379.18%30.6M-127.09%-739.48K-109.23%-113.09K--11.24M
-Including: Investment income associates 392.73%1.94M126.44%1.06M--------53.97%-662.67K-21.23%-4M---------1,221.38%-1.44M---3.3M
Asset deal income ------------99.84%-3.82K79.37%-1.36K-8,364.51%-2.54M-10,261.63%-2.51M-9,246.92%-2.41M56.55%-6.59K1.82%-30.05K
Other revenue 91.41%1.61M74.10%20.59M-62.67%3.91M-77.07%1.97M-67.70%843.37K54.85%11.83M269.92%10.47M424.29%8.6M328.92%2.61M-27.33%7.64M
Operating profit -62.76%29.02M6.34%255.27M-1.74%191.33M31.22%147.02M41.89%77.92M24.73%240.05M37.96%194.72M20.62%112.05M14.90%54.92M22.24%192.45M
Add:Non operating Income 113.46%237.28K641.47%3.15M-29.88%254.04K-15.45%190.69K21.73%111.16K-86.39%424.2K-88.45%362.29K-92.59%225.53K43.45%91.32K818.43%3.12M
Less:Non operating expense 25,623.96%244.05K52.30%998.83K44.83%678K106.28%561.61K-99.46%948.74-10.90%655.81K-1.99%468.13K-20.18%272.26K140.52%177.08K-12.06%736.03K
Total profit -62.83%29.01M7.34%257.42M-1.90%190.91M30.94%146.65M42.32%78.03M23.09%239.82M35.34%194.61M17.16%112M14.74%54.83M24.15%194.84M
Less:Income tax cost -86.94%1.55M-23.03%23.53M-24.87%18.08M12.23%15.52M54.36%11.89M35.24%30.57M30.38%24.06M15.17%13.83M26.41%7.7M3.59%22.61M
Net profit -58.49%27.46M11.77%233.88M1.34%172.83M33.57%131.13M40.35%66.14M21.50%209.25M36.07%170.55M17.45%98.17M13.04%47.13M27.47%172.23M
Net profit from continuing operation -58.49%27.46M11.77%233.88M1.34%172.83M33.57%131.13M40.35%66.14M21.50%209.25M36.07%170.55M17.45%98.17M13.04%47.13M27.47%172.23M
Less:Minority Profit ---2.92M--7.21M--1.46M----------------------------
Net profit of parent company owners -54.08%30.37M8.33%226.67M0.48%171.38M33.57%131.13M40.35%66.14M21.50%209.25M36.07%170.55M17.45%98.17M13.04%47.13M27.47%172.23M
Earning per share
Basic earning per share -53.66%0.196.77%1.420.00%1.0932.26%0.827.89%0.41-6.99%1.334.73%1.09-10.14%0.62-15.56%0.38-26.29%1.43
Diluted earning per share -53.66%0.196.77%1.420.00%1.0932.26%0.827.89%0.41-6.99%1.334.73%1.09-10.14%0.62-15.56%0.38-26.29%1.43
Other composite income
Total composite income -58.49%27.46M11.77%233.88M1.34%172.83M33.57%131.13M40.35%66.14M21.50%209.25M36.07%170.55M17.45%98.17M13.04%47.13M27.47%172.23M
Total composite income of parent company owners -54.08%30.37M8.33%226.67M0.48%171.38M33.57%131.13M40.35%66.14M21.50%209.25M36.07%170.55M17.45%98.17M13.04%47.13M27.47%172.23M
Total composite income of minority owners ---2.92M--7.21M--1.46M----------------------------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Zhonghui Certified Public Accountants (Special General Partnership)------Zhonghui Certified Public Accountants (Special General Partnership)------Zhonghui Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg